214 related articles for article (PubMed ID: 31884893)
1. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9.
Liang Z; Xu J; Ma Z; Li G; Zhu W
Bioengineered; 2020 Dec; 11(1):70-80. PubMed ID: 31884893
[TBL] [Abstract][Full Text] [Related]
2. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
6. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M
Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-218 by nicotine promotes cell proliferation through targeting CDK6 in non-small cell lung cancer.
Liu Z; Lu C; Zhao G; Han X; Dong K; Wang C; Guan JZ; Wang Z
J Cell Biochem; 2019 Oct; 120(10):18370-18377. PubMed ID: 31190333
[TBL] [Abstract][Full Text] [Related]
8. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
9. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
10. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
11. miR-377 inhibited tumorous behaviors of non-small cell lung cancer through directly targeting CDK6.
Zhang J; Zhao M; Xue ZQ; Liu Y; Wang YX
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4494-4499. PubMed ID: 27874949
[TBL] [Abstract][Full Text] [Related]
12. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
[TBL] [Abstract][Full Text] [Related]
15. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma.
Wang Q; Liu S; Zhao X; Wang Y; Tian D; Jiang W
Cancer Med; 2017 Jun; 6(6):1323-1330. PubMed ID: 28440022
[TBL] [Abstract][Full Text] [Related]
16. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
17. miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
Zhu W; Yu Y; Fang K; Xiao S; Ni L; Yin C; Huang X; Wang X; Zhang Y; Le HB; Cui R
Cancer Med; 2023 Feb; 12(4):4590-4604. PubMed ID: 36172919
[TBL] [Abstract][Full Text] [Related]
18. Puerarin alleviates the progression of non-small cell lung cancer by regulating the miR-342/CCND1 axis.
Huang SR; Jin SS; Xu B; Wang RP
Neoplasma; 2020 Nov; 67(6):1244-1255. PubMed ID: 32749850
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
20. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]